Symptomatic therapy for ankylosing spondylitis
The paper characterizes ankylosing spondylitis (AS), one of the common spinal inflammatory diseases, in which not only sacroiliac, peripheral, and root (shoulder and hip) joints, but also the aorta, heart valve apparatus, myocardium, bronchopulmonary system, kidneys, nerve system, and the organ of v...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2012-03-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/405 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849691480976785408 |
|---|---|
| author | Vladimir Vasilyevich Badokin |
| author_facet | Vladimir Vasilyevich Badokin |
| author_sort | Vladimir Vasilyevich Badokin |
| collection | DOAJ |
| description | The paper characterizes ankylosing spondylitis (AS), one of the common spinal inflammatory diseases, in which not only sacroiliac, peripheral, and root (shoulder and hip) joints, but also the aorta, heart valve apparatus, myocardium, bronchopulmonary system, kidneys, nerve system, and the organ of vision are involved in the pathological process. It is stated that the relatively high prevalence of AS, its young onset, progressively reduced spinal mobility, and early disability in the patients require active anti-inflammatory therapy. Significant progress in the treatment of AS is associated with the introduction of gene engineering biologicals into clinical practice. At the same time symptomatic therapy (nonsteroidal anti-inflammatory drugs, glucocorticoids, simple analgesics, myorelaxants) is noted to play an important role in AS. Myorelaxants actively affect not only the major manifestations (pain and rigidity) of AS, but also the functional state of the locomotor apparatus and the outcome of the disease as a whole. By reducing muscle tone and the degree of rigidity, they contribute to increased movement amplitudes in the spine and peripheral joints. Among the drugs of this group, the central myorelaxant mydocalm is most commonly used in Russia. |
| format | Article |
| id | doaj-art-a39a8cd1ea77425bb4824ddc45a0e273 |
| institution | DOAJ |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2012-03-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-a39a8cd1ea77425bb4824ddc45a0e2732025-08-20T03:21:01ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2012-03-0161697410.14412/1996-7012-2012-7201710Symptomatic therapy for ankylosing spondylitisVladimir Vasilyevich BadokinThe paper characterizes ankylosing spondylitis (AS), one of the common spinal inflammatory diseases, in which not only sacroiliac, peripheral, and root (shoulder and hip) joints, but also the aorta, heart valve apparatus, myocardium, bronchopulmonary system, kidneys, nerve system, and the organ of vision are involved in the pathological process. It is stated that the relatively high prevalence of AS, its young onset, progressively reduced spinal mobility, and early disability in the patients require active anti-inflammatory therapy. Significant progress in the treatment of AS is associated with the introduction of gene engineering biologicals into clinical practice. At the same time symptomatic therapy (nonsteroidal anti-inflammatory drugs, glucocorticoids, simple analgesics, myorelaxants) is noted to play an important role in AS. Myorelaxants actively affect not only the major manifestations (pain and rigidity) of AS, but also the functional state of the locomotor apparatus and the outcome of the disease as a whole. By reducing muscle tone and the degree of rigidity, they contribute to increased movement amplitudes in the spine and peripheral joints. Among the drugs of this group, the central myorelaxant mydocalm is most commonly used in Russia.https://mrj.ima-press.net/mrj/article/view/405ankylosing spondylitisanti-inflammatory therapysymptomatic treatmentmyorelaxants |
| spellingShingle | Vladimir Vasilyevich Badokin Symptomatic therapy for ankylosing spondylitis Современная ревматология ankylosing spondylitis anti-inflammatory therapy symptomatic treatment myorelaxants |
| title | Symptomatic therapy for ankylosing spondylitis |
| title_full | Symptomatic therapy for ankylosing spondylitis |
| title_fullStr | Symptomatic therapy for ankylosing spondylitis |
| title_full_unstemmed | Symptomatic therapy for ankylosing spondylitis |
| title_short | Symptomatic therapy for ankylosing spondylitis |
| title_sort | symptomatic therapy for ankylosing spondylitis |
| topic | ankylosing spondylitis anti-inflammatory therapy symptomatic treatment myorelaxants |
| url | https://mrj.ima-press.net/mrj/article/view/405 |
| work_keys_str_mv | AT vladimirvasilyevichbadokin symptomatictherapyforankylosingspondylitis |